These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 15855637)

  • 41. Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin.
    Chen ES; Greenlee BM; Wills-Karp M; Moller DR
    Am J Respir Cell Mol Biol; 2001 May; 24(5):545-55. PubMed ID: 11350823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: modulation of the expression of TGF-β1 and iNOS.
    Gungor H; Ekici M; Onder Karayigit M; Turgut NH; Kara H; Arslanbas E
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1659-1670. PubMed ID: 32377772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
    Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT
    J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Essential role of stem cell factor-c-Kit signalling pathway in bleomycin-induced pulmonary fibrosis.
    Ding L; Dolgachev V; Wu Z; Liu T; Nakashima T; Wu Z; Ullenbruch M; Lukacs NW; Chen Z; Phan SH
    J Pathol; 2013 Jun; 230(2):205-14. PubMed ID: 23401096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Obaculactone protects against bleomycin-induced pulmonary fibrosis in mice.
    Wang X; Ouyang Z; You Q; He S; Meng Q; Hu C; Wu X; Shen Y; Sun Y; Wu X; Xu Q
    Toxicol Appl Pharmacol; 2016 Jul; 303():21-29. PubMed ID: 27180239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myeloid cell dynamics in bleomycin-induced pulmonary injury in mice; effects of anti-TNFα antibody.
    Venosa A; Gow JG; Taylor S; Golden TN; Murray A; Abramova E; Malaviya R; Laskin DL; Gow AJ
    Toxicol Appl Pharmacol; 2021 Apr; 417():115470. PubMed ID: 33647319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcription factor ets-2 plays an important role in the pathogenesis of pulmonary fibrosis.
    Baran CP; Fischer SN; Nuovo GJ; Kabbout MN; Hitchcock CL; Bringardner BD; McMaken S; Newland CA; Cantemir-Stone CZ; Phillips GS; Ostrowski MC; Marsh CB
    Am J Respir Cell Mol Biol; 2011 Nov; 45(5):999-1006. PubMed ID: 21562315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.
    Fujimoto H; Gabazza EC; Taguchi O; Nishii Y; Nakahara H; Bruno NE; D'Alessandro-Gabazza CN; Kasper M; Yano Y; Nagashima M; Morser J; Broze GJ; Suzuki K; Adachi Y
    Am J Pathol; 2006 Apr; 168(4):1086-96. PubMed ID: 16565485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis.
    Rullier A; Gillibert-Duplantier J; Costet P; Cubel G; Haurie V; Petibois C; Taras D; Dugot-Senant N; Deleris G; Bioulac-Sage P; Rosenbaum J
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G226-35. PubMed ID: 17962354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis.
    Kulkarni AA; Thatcher TH; Hsiao HM; Olsen KC; Kottmann RM; Morrissette J; Wright TW; Phipps RP; Sime PJ
    PLoS One; 2013; 8(5):e63798. PubMed ID: 23741300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. STAT1-dependent and -independent pulmonary allergic and fibrogenic responses in mice after exposure to tangled versus rod-like multi-walled carbon nanotubes.
    Duke KS; Taylor-Just AJ; Ihrie MD; Shipkowski KA; Thompson EA; Dandley EC; Parsons GN; Bonner JC
    Part Fibre Toxicol; 2017 Jul; 14(1):26. PubMed ID: 28716119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis.
    Liu Q; Jiang JX; Liu YN; Ge LT; Guan Y; Zhao W; Jia YL; Dong XW; Sun Y; Xie QM
    Toxicol Lett; 2017 May; 273():1-9. PubMed ID: 28300665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension.
    Tam AYY; Horwell AL; Trinder SL; Khan K; Xu S; Ong V; Denton CP; Norman JT; Holmes AM; Bou-Gharios G; Abraham DJ
    Int J Biochem Cell Biol; 2021 May; 134():105961. PubMed ID: 33662577
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
    Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
    Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationships between early inflammatory response to bleomycin and sensitivity to lung fibrosis: a role for dipeptidyl-peptidase I and tissue inhibitor of metalloproteinase-3?
    Pottier N; Chupin C; Defamie V; Cardinaud B; Sutherland R; Rios G; Gauthier F; Wolters PJ; Berthiaume Y; Barbry P; Mari B
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1098-107. PubMed ID: 17673693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice.
    Zhu T; Zhang W; Xiao M; Chen H; Jin H
    Int J Mol Sci; 2013 Dec; 14(12):23581-96. PubMed ID: 24300094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activated alveolar epithelial cells initiate fibrosis through autocrine and paracrine secretion of connective tissue growth factor.
    Yang J; Velikoff M; Canalis E; Horowitz JC; Kim KK
    Am J Physiol Lung Cell Mol Physiol; 2014 Apr; 306(8):L786-96. PubMed ID: 24508728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
    Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" BALB/c mouse lungs.
    Bonniaud P; Martin G; Margetts PJ; Ask K; Robertson J; Gauldie J; Kolb M
    Am J Respir Cell Mol Biol; 2004 Nov; 31(5):510-6. PubMed ID: 15256388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.